Ignite Creation Date:
2024-05-06 @ 12:12 PM
Last Modification Date:
2024-10-26 @ 12:56 PM
Study NCT ID:
NCT03707847
Status:
UNKNOWN
Last Update Posted:
2018-10-16
First Post:
2018-09-23
Brief Title:
Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK ALCL
Sponsor:
Mingzhi Zhang
Organization:
Zhengzhou University
Organization Data
Organization:
Zhengzhou University
Class:
OTHER
Study ID:
hnslblzlzx20180821
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mingzhi Zhang
Lead Sponsor Class:
OTHER
Responsible Party:
Mingzhi Zhang
Responsible Party Title:
the director of oncology department of the first affiliated hospital
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Zhengzhou University
Old Name:
None
Old Organization:
None